GB9710820D0 - Immunological method - Google Patents
Immunological methodInfo
- Publication number
- GB9710820D0 GB9710820D0 GBGB9710820.3A GB9710820A GB9710820D0 GB 9710820 D0 GB9710820 D0 GB 9710820D0 GB 9710820 A GB9710820 A GB 9710820A GB 9710820 D0 GB9710820 D0 GB 9710820D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- immunological method
- immunological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001900 immune effect Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9710820.3A GB9710820D0 (en) | 1997-05-27 | 1997-05-27 | Immunological method |
EP98924427A EP1017724A2 (en) | 1997-05-27 | 1998-05-27 | Immunological method |
AU76631/98A AU728909B2 (en) | 1997-05-27 | 1998-05-27 | Immunological method |
PCT/GB1998/001382 WO1998054223A2 (en) | 1997-05-27 | 1998-05-27 | Immunological method |
CA002291004A CA2291004A1 (en) | 1997-05-27 | 1998-05-27 | Immunological method |
JP50035099A JP2001517958A (en) | 1997-05-27 | 1998-05-27 | Immunological method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9710820.3A GB9710820D0 (en) | 1997-05-27 | 1997-05-27 | Immunological method |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9710820D0 true GB9710820D0 (en) | 1997-07-23 |
Family
ID=10813057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9710820.3A Pending GB9710820D0 (en) | 1997-05-27 | 1997-05-27 | Immunological method |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1017724A2 (en) |
JP (1) | JP2001517958A (en) |
AU (1) | AU728909B2 (en) |
CA (1) | CA2291004A1 (en) |
GB (1) | GB9710820D0 (en) |
WO (1) | WO1998054223A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1243327A1 (en) * | 2001-03-19 | 2002-09-25 | BioChip Technologies GmbH | Suface with a pattern of cells and method for its production |
GB0128153D0 (en) * | 2001-11-23 | 2002-01-16 | Bayer Ag | Profiling of the immune gene repertoire |
CN1842603B (en) | 2003-06-27 | 2013-09-11 | 株式会社国际癌症免疫研究所 | Method of selecting wt1 vaccine adaptive patient |
KR101900639B1 (en) * | 2007-03-05 | 2018-09-19 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
JP6066909B2 (en) * | 2011-06-28 | 2017-01-25 | 株式会社癌免疫研究所 | Peptide cancer antigen-specific T cell receptor gene |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2671356B1 (en) * | 1991-01-09 | 1993-04-30 | Inst Nat Sante Rech Med | METHOD FOR DESCRIBING ANTIBODY (AB) DIRECTORIES AND T CELL RECEPTORS (TCR) IN THE INDIVIDUAL'S IMMUNE SYSTEM. |
WO1993004695A1 (en) * | 1991-08-28 | 1993-03-18 | The Wistar Institute | T cell receptor-based therapy for rheumatoid arthritis |
WO1994014067A1 (en) * | 1992-12-14 | 1994-06-23 | T Cell Sciences, Inc. | Diagnosis and therapy of sarcoidosis |
WO1998001738A2 (en) * | 1996-06-20 | 1998-01-15 | Cornell Research Foundation, Inc. | Identification of abnormalities in the expression of t and b cell antigen receptors as disease indicators |
-
1997
- 1997-05-27 GB GBGB9710820.3A patent/GB9710820D0/en active Pending
-
1998
- 1998-05-27 CA CA002291004A patent/CA2291004A1/en not_active Abandoned
- 1998-05-27 EP EP98924427A patent/EP1017724A2/en not_active Withdrawn
- 1998-05-27 JP JP50035099A patent/JP2001517958A/en active Pending
- 1998-05-27 WO PCT/GB1998/001382 patent/WO1998054223A2/en not_active Application Discontinuation
- 1998-05-27 AU AU76631/98A patent/AU728909B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU7663198A (en) | 1998-12-30 |
WO1998054223A3 (en) | 1999-03-04 |
JP2001517958A (en) | 2001-10-09 |
EP1017724A2 (en) | 2000-07-12 |
CA2291004A1 (en) | 1998-12-03 |
AU728909B2 (en) | 2001-01-18 |
WO1998054223A2 (en) | 1998-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9717766D0 (en) | Methods | |
HUP0000911A3 (en) | Refuse-treatment method | |
GB9721603D0 (en) | Method | |
GB2345063B (en) | Method | |
GB9706282D0 (en) | Method | |
PL334701A1 (en) | Novel method | |
GB9700320D0 (en) | Method | |
GB9708918D0 (en) | Methods | |
GB9707744D0 (en) | Method | |
GB9707742D0 (en) | Methods | |
ZA9810471B (en) | New method | |
IL121534A0 (en) | Immunoassay method | |
GB9718591D0 (en) | Methods | |
GB9717652D0 (en) | Method | |
GB9710820D0 (en) | Immunological method | |
PL341657A1 (en) | Deparaffining method | |
HUP9701386A3 (en) | Immunoassay method | |
GB9725462D0 (en) | Novel method | |
GB9709811D0 (en) | Method | |
GB9701894D0 (en) | Method | |
GB9715266D0 (en) | Novel method | |
GB9715150D0 (en) | Novel method | |
GB9705683D0 (en) | Novel method | |
GB9700940D0 (en) | Novel method | |
GB9715269D0 (en) | Novel method |